With new technologies emerging today, the importance of stem cells in the cell therapy of nervous system diseases is supported by recent studies. Therefore, the development of neuronal cell differentiation protocols from stem cells is of great importance. In our study, the differentiation of neuronal and neuroglial cells from mouse embryonic stem (ES) cell line and their analysis with neuronal cell markers are aimed. Mouse ES cells were differentiated to neurogenic series cells by adding N2 and bFGF to the culture medium on coated Fibronectin dishes. For the identification of differentiated cells, they were evaluated by light microscopy using immunhistochemistry techniques and by electron microscopy. Indirect immunohistochemical staining method was performed with SSEA-1 (mouse embriyonic stem cells marker), Nestin (neural precursor cells marker), βIII-Tubulin (neuronal cells marker), MAP-2 (neuronal cells marker), GFAP (astrocyte marker), and O4 (oligodendrocyte marker). After 1 week of differentiation of cells, immunoreactivities of SSEA-1 and Nestin were detected to be negative and moderate, respectively. After 2 weeks culture time, the differentiation was still continuing and especially positive immunoreactivities of β-III Tubulin and MAP-2 and weak immunoreactivities of O4 and GFAP were supported neuronal differentiation. In conclusion, our results suggest that neuronal cell derived from mouse ES cells were differentiated particularly to neuron using N2+bFGF+fibronectin culture condition. Therefore, these differentiated cells may be used as a treatment method in degenerative diseases of the nervous system.
INTRODUCTION
The differentiation of neuronal cells from stem cells plays an important role in the cell therapy of nervous system diseases, including neurodegenerative disorders, multiple sclerosis, neurotrauma and neurodevelopmental disorders [1] . Recent clinical trials of regenerative therapy for neuronal disease have been performed with transplantation of stem cells [2] . Stem cells using neuronal disease models; somatic (adult derived) stem cells, fetal stem cells and ES cells, induced pluripotent stem (iPS) cells [3] . Numerous studies of transplantation of somatic stem cells using neuronal disease models have been reported and most studies have confirmed its efficiency in repairing these [2] . The transplantation effect of adipose derived mesenchymal stem cells has been reported to be greater than that of bone marrow mesenchymal stem cells [2] . iPS cells have been shown to differentiate towards a neuronal phenotype leading to functional improvement after their application in animal models of Parkinson's disease, stroke and other pathologies [3] . Fetal stem cells demonstrate higher proliferation, more specific differentiation, and better migration after transplantation. However, the use of these cells is limited [3, 4] . ES cells are pluripotent stem cells [5] . Studies have shown that they can proliferate undifferentiated in vitro [6] . These cells have been shown to proliferate without differentiation in suitable culture medium, but changing the environment may lead these cells to differentiate [7] [8] [9] . Furthermore, ES cells have been reported to generate all three neural lineages: neurons, astrocytes and oligodendrocytes [10] [11] [12] . Several approaches have been used to achieve in vitro neural differentiation starting from ES cells, aimed at generating specified neural progenitors and/or differentiated neuronal and glial subtypes [10, 13] . Differentiation of stem cells to neurons has usually been achieved by protocols that enrich ectoderm derivatives, as a first step in the production of neural progenitors [12, 14] . These attempts to influence cell fate decisions in order to obtain cells of the ectodermal layer have utilized neuralizing signals derived from feeder cells, addition of growth factors or growth supplements to the medium [12, [15] [16] [17] .
In this study, neural cell differentiation from mouse embryonic stem cells was indicated by neural and glial cells specific markers. Differentiated neuronal cells were identified with stage specific embryogenic antigen-1 (SSEA-1), nestin, βIII-Tubulin, microtubule associated protein (MAP-2), glial fibrillary acidic protein (GFAP), and oligodendrocyte 4 (O4) antigens. SSEA-1 is a carbohydrate antigen that can be identified in mouse and human embryonic stem cells. SSEA-1 is positive in preimplantation stage of mouse embryos while it is lost during differentiation [18] . Nestin is type VI intermediate filament protein and is synthesized in dividing cells during early development, especially in primitive neuroepithelium. Nestin is expressed by neuronal precursor cells. They are down regulated with differentiation of neuronal stem cells [19, 20] . MAP-2 is responsible for microtubule formation and shaping dendritic in neurogenesis [21, 22] . βIII-Tubulin is widely as an early neuronal cytoskeleton marker in neuronal development studies [23, 24] . GFAP is a specific intermediate filament protein that is expressed by numerous cell types of central nervous system. It is associated with many cellular functions, such as cellular structure and movement, in neuronal cells [25] [26] [27] . O4 has been commonly used as the earliest recognized marker specific for the oligodendroglial lineage [28] .
Recently, in diseases of the nervous system, many studies have been done regarding stem cell therapy. Therefore, the forming nerve cell production protocols from stem cells is essential.This study is important in constituting a study protocol for nerve cells derived from embryonic stem cell in different time periods in medium containing basic fibroblast growth factor (bFGF) and N2 on fibronectin coated plates.
MATERIAL and METHODS
The study protocols and experimental procedures were approved by the Celal Bayar University Scientific Ethics Committee (0259).
Embryonic Stem Cell Culture and Neuronal Differentiation
Mouse embryonic stem cell line (CGR8, 07032901, ECACC, Salisbury, UK) was purchased from the Celal Bayar University Medical Faculty, Histology and Embryology Department. For the feeder layer, mouse fibroblast cells (STO, 86.032.003, ECACC, Salisbury, UK) were used. When the STO cells became confluent after 1 week of culture, they were treated with 20 μg/ml of mitomycin-C (A2190, 0002, Applichem, Darmstadt, Germany) for 1.5h at 37°C with 5% CO 2 in air. Incubation of STO cells with mitomycin-C and embryonic stem cell cultures, was performed simultaneously.
Embryonic stem cells were cultured in a humidified atmosphere at 37°C in 5% CO 2 in a medium [Dulbecco's modified Eagle's medium (DMEM, F0445, Biochrom AG, Berlin, Germany) containing 4500 mg/l glucose and sodium pyruvate,15% fetal bovine serum (FBS, S0113, Biochrom AG, Berlin, Germany), 1% l-glutamine (K0283, Biochrom AG, Berlin, Germany), 1% penicillin/streptomycin (A2213, Biochrom AG, Berlin, Germany), 0.1 mM non-essential amino acid (NEAA, K0293, Biochrom AG, Berlin, Germany), 10 −6 M β-mercaptoethanol (M7522, Sigma-Aldrich, St. Louis, MO, USA) and 1.000 IU/ml leukemia inhibitory factors (LIF, L5158 Sigma-Aldrich St. Louis, MO, USA)] on mitomycin-C treated STO cells. The medium was changed every other day. When the cells were confluent, they were routinely subcultured using trypsin-EDTA solution (L2143, Biochrom AG, Berlin, Germany). The hanging drop method was used for forming embryoid bodies (EBs) from embryonic stem cells. On the lid of culture dishes, 20 μl drops containing 5×10 4 undifferentiated cells/ml were plated. The lid was inverted and placed over the culture dish filled with sterile phosphate buffered saline (PBS) to prevent the drops from drying [29] . The culture dishes with hanging drops were incubated in a humidified atmosphere at 37°C in 5% CO 2 for 2 days. Embryoid bodies were collected into media and then were transferred into culture dishes. Cells were cultured in a humidified atmosphere at 37°C in 5% CO 2 for 4 days in culture medium without LIF. 1% N2 solution (R&D System, SC005, USA), containing bovine insulin, human transferrin, sodium selenite, putrescine and progesterone, was added into culture media for neural stem cell expansion. When the cells were confluent, they were transferred to 1% bovine fibronectin (Neural Stem Cell Expansion Kit Monolayer Plus System, SC005, USA) coated plates. Fibronectin used to promote cell attachment and spreading. On the seventh day of the culture, some of the cells were fixed for immunohistochemical analysis, while 0.1% bFGF (Neural Stem Cell Expansion Kit Monolayer Plus System, SC005, USA) was added to the remaining cells to maintain the differentiation. These cells were passed through on the seventh, fourteenth and twenty-first days of the culture, and were fixed for immunohistochemical analysis.
Identification of Neuronal Differentiation Using Transmission Electron Microscopy
Cells were collected after 2 weeks of culture period using trypsinization technique. They were fixed with 2.5% glutaraldehyde (16210, Electron Microscopy Sciences, Hatfield, PA). After washing with buffer solution (Buffer A: 0.06 M KH 2 PO 4 + Buffer B: 0.08 M Na 2 HPO 4 ) twice, 10 min for each step, the pellets were fixed with 1% osmium tetroxide (R1015, Agar Scientific, Essex, UK) at +4°C for 1 hour. Cells were embedded in 2% agar (A 2114, AppliChem, Darmstadt, Germany) after washing with buffer solution for 10 min. They were dehydrated with propylene oxide and embedded in epon. Thin sections (120 nm) were contrasted with uranyl acetate and lead citrate. They were evaluated under Zeiss LIBRA 120 electron microscope (Oberkochen, Germany).
Identification of Neuronal Differentiation Using Indirect Immunoperoxidase Staining
For immunohistochemical analysis, cells were stained using the indirect immunohistochemical method. The differentiated cells were fixed with 4% paraformaldehyde in PBS at 4°C for 30 min. Subsequently, they were washed with PBS. Endogenous peroxidase activity was quenched with incubation with 3% hydrogen peroxide (H 2 O 2 , K31355100, Merck, Darmstadt, Germany) for 10 min at room temperature. Cells were then washed with PBS, and incubated on ice for 15 min with 0.1% Triton-X (A4975,0100, Applichem, Darmstadt, Germany) for permeabilization.
Afterwards, cells were incubated with blocking solution (K023, DBS, California, USA) for 1 h. Cells were then washed with PBS, and incubated with primary antibodies: anti-SSEA-1 (1:5 dilution, R&D System, MAB2155, USA), anti-Nestin (1:10 dilution, (R&D System, SC 013, USA), anti-βIII-Tubulin (1:10 dilution, R&D System, SC 013, USA), anti-GFAP (1:100 dilution, R&D System, SC 013), anti-O4 (1:10 dilution, R&D System, SC 013, USA), and anti-MAP-2 (1:100 dilution, Gene-Tex, GTX 48032, USA), all for overnight at room temperature in a humidified chamber. After removing the primary antibodies, the cells were incubated with biotinylated IgG (both anti-mouse and anti-goat supplied ready to use by Zymed, San Francisco, CA, USA) for 30 min, followed by three washes in PBS and then with streptavidin-peroxidase conjugate (supplied ready to use by Zymed) for 30 min (Histostain-Plus Bulk Kits; Zymed) and washed with PBS three times. They were incubated with a solution containing 1:9 concentration of diaminobenzidine (supplied ready to use by Zymed) with 0.3% H 2 O 2 (Histostain-Plus Bulk Kits; Zymed), 50 μl for each sample, for 5 min to visualize immunolabeling. Samples were then mounted with mounting medium (AML060, Scytek, Logan, UT, USA). Subsequently, they were viewed using an IX71 inverted microscope (Olympus, Tokyo, Japan). The negative controls received the same treatment as described above, but they were incubated with rabbit IgG instead of the primary antisera [29] . Labelling in all negative control cases was negative. Immunolabelling was evaluated semi-quantitatively using an additive immuno reactive score reflecting signal intensity, as negative (−), mild (+), moderate (++) and strong (+++).
Statistical Analysis
Comparable data groups were evaluated using ANOVA. P<0.05 was considered significant [30] . Graph-Pad InStat statistic program (GraphPad Software, USA) was used for analyses.
RESULTS
It was observed that mouse embryonic stem cells were round-shaped with bright nuclei and they formed inexplicit-contoured colonies on the confluent mitomycin treated STO (Fig. 1A, B) . Both the outer and the inner layer cells were distinguishable within the embryonic bodies formed from the embryonic stem cells after the hanging drop method. It was observed that the outer layer cells were composed of cubic surface ectoderm-like single layer cells significantly (Fig. 2A) . The peripheral cells were seen to have proliferated forward as well (Fig. 2B) .
For neuronal differentiation, N2 medium was added into culture condition at fourth day of culture. Some of the cells were observed as fusiform-shaped, while the others had round bodies and axon-dendrite-like extensions just like neurons on the 7 th day of differentiation (Fig. 3A) . (Fig. 3B,C) (Fig. 4) . After TEM analyses, the cells which were cultured in N2+bFGF medium for 9 days consisted lamellipodia, large euchromatic nuclei and sparse endoplasmic reticulum and golgi (Fig. 4A) . Neuron-like cells have mitochondria which have more prominent cristae and distinguishable microtubules which is an indicator of mature neurons (Fig. 4B) . Immunohistochemical Results: According to the immunohistochemical analyses performed in order to characterize the cells on the 7 th and 14 th days of differentiation, SSEA-1 immunoreactivity, which is a mouse embryonic stem cell marker, was weak and negative (0.9±0.17), (0.1±0.19) respectively (Fig. 5A,B) , whereas the immunoreactivity of Nestin, which is an anti-body specific to the intermediate filament proteins of neural precursor cells, was strongly and weakly positive on the 7 th and 14 th days of the culture within N2 medium, (2.8±0.18), (1.08±0.10) respectively (Fig. 5C, D) . SSEA-1 and Nestin immunoreactivites in both 7 th and 14 th were statistically different (P<0.001), (P<0.001) respectively. In particularly, statistical significance of nestin immuno-reactivity supported that cells were derived from embryonic cells differentiated to neuron precursor at the 7 th day of culture in our differentiated condition.
UMUR, VATANSEVER, UMUR TÜRKÖZ, ÖZBİLGİN
On the 14 th and 21 st days of culture, the neuronal cell markers MAP-2 (Fig. 6A,B) and ßIII-Tubulin (Fig. 6C,D) immunoreactivites were strongly positive, whereas the neuroglial cell markers GFAP (Fig. 6E,F) and O4 (Fig. 6G,H Table 2 .
DISCUSSION
The nervous system is controlled by a series of epigenetic and cellular endogeneous signals during embryogenesis and early postnatal life, and differentiates from the neural tube derived from the configuration of the neuroectoderm [31] . All the central nervous system elements (neurons, glial cells, ependymal cells, etc.) are inside this structure. The structural elements of the nervous tissue are completed by the formation of certain cells and structures by the crista neuralis, which is derived from the neuroectoderm. The neurons and neuroglia cells that were derived from their precursors during neurogenic UMUR, VATANSEVER, UMUR TÜRKÖZ, ÖZBİLGİN development complete their differentiation in the embryonic period. The extreme differentiation of the nerve cells makes them the ultimate controller of all the other cells in the organism. The nerve cells are ultimately developed during the embryogenic development. This situation eliminates their regeneration and proliferation ability in adult nerve cells. This is why the degenerative disorders of the nervous system cannot be amended [32] .
Recently, many studies have aimed to clarify the mechanisms that will enable the replacement of the damaged tissues and perform nervous transmission. Thus, nervous cells that may be differentiated both from embryonic or extraembryonic derived stem cells are of great importance.
One of the most important factors determining the development and differentiation of stem cells during the embryonic development is the environment. The cell is differentiated depending on its environment and the signal molecules it is exposed to. The signal molecules build up the micro-environment of the cell [10] . Depending on the settlement within the micro-environment of the cell and certain intrinsic factors, stem cells may enlarge the cellular pool with divisions, turn into different cell lines and progress into programmed cell death [33] . Multiple different protocols exist for achieving neural induction and differentiation of ES cells. For example, the pluripotent cells can differ depending on the altering cell culture condition such as culturing on matrigel, mouse embryonic fibroblast, and fibronectin coated plates. In addition, neural induction methods from embryonic stem cells also vary which can include embryoid bodies, adherent monolayers, and rosette formation of ES cells. In our condition, we used fibronectin as an extracellular matrix component, bFGF as an inductive factor and N2 as a supportive medium to neuronal lineage differentiation.
Neural differentiation was first experienced in embryonal carsinoma cells. Following the retinoic acid in vitro exposure of P19 (EC cell line) and embryo derived pluripotential stem cell line, they differentiated into neural cells [10, 11, 34, 35] . Different studies have utilized other signal molecules such as βNGF, FGF, Wnt, TGF-β and N2 with different protocols in order to promote neural differentiation [14, 36, 37] .
In our study, a micro-environment was created by mouse fibroblast cells as a feeder layer for mouse embryonic stem cells. The physical conditions of the cells were changed using N2 and bFGF, and their differentiation into neuronal cells and proliferation were promoted. The N2 medium provides the growth of neural stem cells in vitro, and contains insulin, transferrin, sodium selenite, putrescine, and progesterone. bFGF is a mitogen agent that is used in order to promote the proliferation of the neural precursor cells [38] [39] [40] [41] [42] [43] . The media supplemented with N2 and bFGF induced embriyonic stem cells to differentiate into more complex neuron-like cells.
At the beginning of the study, the maintenance of the pluripotent properties of the ES cells was provided using nutritive cell layers (STO fibroblast cells) and LIF. After culturing EB cells derived from ES cells in the absence of LIF in culture dishes until the fourth day of the experiment, N2 was added into the ESC differentiation culture medium. The positivity of SSEA-1 and nestin immunoreactivity in the culture at the end of the seventh day showed that these were embryonic stem cells and precursor neuro-genic cells. The lower immunoreactivity of SSEA-1 on the 7 th day showed that the embryonic stem cells had begun to differentiate. The positive immunoreactivity of nestin on the7 th day indicated that the cells had begun to differentiate into neuron precursor cells in accordance with the decrease in the SSEA-1 immunoreactivity. This result suggested that this culture condition lead to the differentiation of mouse embriyonic stem cells into neuro-genic progenitor cells.
The results of immunohistochemical analyses after 14 days of culture time, the strong positivity of βIII-Tubulin and MAP-2 immunoreactivities, which were neuronal cell indicators, and the weak positivity of O4 and GFAP immunoreactivities, which were oligodentrocytes and astrocytes markers, were observed respectively. The data suggested that the cells had begun to differentiate into neurogenic (neurons, oligodendrocytes, astrocytes etc.) cells from the precursor cells. The increased immunoreactivities of βIII-Tubulin and MAP-2 compared to those of O4 and GFAP on the 21 st day suggested that the differentiation protocols provided a particular differentiation into neuronal cells.
The protocol used in our study induced the differentiation of a higher number of embryonic stem cells into neurons, while providing a lower potential of differentiation into neuroglial cells. Therefore, it may be concluded that the protocol used is appropriate for neuronal differentiation, and that a different mediator should be added into the culture medium in order to promote the activation of astrocyte and/or oligodendrocyte differentiation. Barres et al. [44] have demonstrated that retrieval of FGF from the medium after the 7 th day of culture and continuation of the culture with T3 addition resulted in a higher oligodendrocyte differentiation from embryonic stem cells.
In the study of Okabe et al. [15] , ES cells were increased in number with the addition of N2 and FGF factors into the medium and they differentiated into neuronal precursor cells, which were shown by the detection of nestin, MAP-2, GFAP and O4 positive cells. These results were similar to the results in our study. However, following the retrieval of FGF from the medium after differentiation, the number of nestinpositive cells in the culture decreased, MAP-2 positive cells increased and GFAP and O4-positive cells were visualized.
In the study of Li et al. [45] , retinoic acid was used for the neural line specification of the embryonic stem cells. Neural progenitor cells were formed on the 7 th day of the culture, neuronal cells were formed on the 10 th day and neuronal line specification and functional neuron formation were completed by the 17 th day, similar to our study. Sox1, Sox 2 and ß Galactosidase indicators were used as neuroepithelial markers in this study in addition to nestin, Pax3, 6 and Islet expressions which were examined as neural markers. Although there are many studies on the use of embryonic stem cells for the differentiation of neuronal cells, it has been demonstrated that mesenchymal stem cells and multipotent adult progenitor cells are also shown to form neurons, oligodendrocytes and astrocytes in humans, mice and rats in vitro [8, [46] [47] [48] [49] [50] [51] .
In conclusion, using the protocols that use the differentiation potentials of embryonic stem cells and considering the cell differentiation criteria of ectodermal serial cells, the cells were demonstrated to start differentiating on the 7 th day and this continued until the 21 st day. It was also observed that, the neuron-like cell differentiation was to a higher extent in particular. It is necessary to analyze the in vivo usability and functionality of the cells that are derived in vitro. This study is important in constituting a study protocol for the analysis of the usability of cells derived from embryonic stem cell differentiation treating nerve cell injuries and degenerative disorders of the nervous system.
